1. |
Semsarian C, Ingles J, Maron MS, et al. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol, 2015, 65(12): 1249-1254.
|
2. |
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要. 中国循环杂志, 2021, 36(6): 521-545.
|
3. |
Rowin EJ, Maron BJ, Olivotto I, et al. Role of exercise testing in hypertrophic cardiomyopathy. JACC Cardiovasc Imaging, 2017, 10(11): 1374-1386.
|
4. |
Hodges K, Rivas CG, Aguilera J, et al. Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center. J Thorac Cardiovasc Surg, 2019, 157(6): 2289-2299.
|
5. |
Rastegar H, Boll G, Rowin EJ, et al. Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: The tufts experience. Ann Cardiothorac Surg, 2017, 6(4): 353-363.
|
6. |
Sorajja P, Binder J, Nishimura RA, et al. Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Catheter Cardiovasc Interv, 2013, 81(1): E58-E67.
|
7. |
Batzner A, Pfeiffer B, Neugebauer A, et al. Survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol, 2018, 72(24): 3087-3094.
|
8. |
Nguyen A, Schaff HV, Hang D, et al. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score-matched cohort. J Thorac Cardiovasc Surg, 2019, 157(1): 306-315.
|
9. |
Kimmelstiel C, Zisa DC, Kuttab JS, et al. Guideline-based referral for septal reduction therapy in obstructive hypertrophic cardiomyopathy is associated with excellent clinical outcomes. Circ Cardiovasc Interv, 2019, 12(7): e007673.
|
10. |
Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation, 2002, 105(4): 539-542.
|
11. |
Writing Committee Members, Ommen SR, Mital S, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Thorac Cardiovasc Surg, 2021, 162(1): e23-e106.
|
12. |
Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet, 1995, 346(8969): 211-214.
|
13. |
Maron BJ. Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy. Circulation, 2007, 116(2): 196-206.
|
14. |
罗晓亮, 袁建松, 杨伟宪. 中国医学科学院阜外医院经皮室间隔心肌消融术临床操作规范. 中国分子心脏病学杂志, 2021, 21(3): 3913-3917.
|
15. |
Veselka J, Jensen MK, Liebregts M, et al. Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: Results from the Euro-ASA registry. Eur Heart J, 2016, 37(19): 1517-1523.
|
16. |
Nagueh SF, Groves BM, Schwartz L, et al. Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry. J Am Coll Cardiol, 2011, 58(22): 2322-2328.
|
17. |
Quintana E, Bajona P, Arguis MJ, et al. Septal myectomy after failed septal alcohol ablation. Ann Cardiothorac Surg, 2017, 6(4): 394-401.
|
18. |
Quintana E, Sabate-Rotes A, Maleszewski JJ, et al. Septal myectomy after failed alcohol ablation: Does previous percutaneous intervention compromise outcomes of myectomy? J Thorac Cardiovasc Surg, 2015, 150(1): 159-167.
|
19. |
Fitzgerald P, Kusumoto F. The effects of septal myectomy and alcohol septal ablation for hypertrophic cardiomyopathy on the cardiac conduction system. J Interv Card Electrophysiol, 2018, 52(3): 403-408.
|
20. |
Valeti US, Nishimura RA, Holmes DR, et al. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol, 2007, 49(3): 350-357.
|
21. |
Talreja DR, Nishimura RA, Edwards WD, et al. Alcohol septal ablation versus surgical septal myectomy: Comparison of effects on atrioventricular conduction tissue. J Am Coll Cardiol, 2004, 44(12): 2329-2332.
|
22. |
Cui H, Schaff HV, Nishimura RA, et al. Conduction abnormalities and long-term mortality following septal myectomy in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol, 2019, 74(5): 645-655.
|
23. |
Ji Q, Wang Y, Yang Y, et al. Surgical septal myectomy for the treatment of residual left ventricular outflow tract obstruction following failed alcohol septal ablation. Int Heart J, 2021, 62(2): 329-336.
|
24. |
Yang Q, Zhu C, Cui H, et al. Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation. J Thorac Dis, 2021, 13(2): 1055-1065.
|
25. |
Wehman B, Ghoreishi M, Foster N, et al. Transmitral septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg, 2018, 105(4): 1102-1108.
|
26. |
Yang DH, Kang JW, Kim N, et al. Myocardial 3-dimensional printing for septal myectomy guidance in a patient with obstructive hypertrophic cardiomyopathy. Circulation, 2015, 132(4): 300-301.
|